Domitor 1 mg/ml solution for injection

Država: Irska

Jezik: engleski

Izvor: HPRA (Health Products Regulatory Authority)

Aktivni sastojci:

Medetomidine hydrochloride

Dostupno od:

Orion Corporation

ATC koda:

QN05CM91

INN (International ime):

Medetomidine hydrochloride

Doziranje:

1 milligram(s)/millilitre

Farmaceutski oblik:

Solution for injection

Tip recepta:

POM: Prescription Only Medicine as defined in relevant national legislation

Terapijska grupa:

Cats, Dogs

Područje terapije:

medetomidine

Terapijske indikacije:

Neurological Preparations

Status autorizacije:

Authorised

Datum autorizacije:

2010-03-12

Svojstava lijeka

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Domitor 1 mg/ml solution for injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Medetomidine hydrochloride
1 mg/ml
(equivalent to 0.85 mg/ml medetomidine)
EXCIPIENTS:
Methyl parahydroxybenzoate (E218)
1 mg/ml
Propyl parahydroxybenzoate
0.2 mg/ml
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection
Clear, colourless solution
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs and cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
DOGS:
For restraint, sedation and analgesia associated with clinical
examinations and procedures, minor surgery and
as premedication before general anaesthesia
In combination with butorphanol for sedation and analgesia
CATS:
For restraint and sedation
In combination with ketamine for the induction of general anaesthesia
prior to surgical procedures
In combination with butorphanol for sedation and analgesia, and
combined with both butorphanol and
ketamine for general anaesthesia
As a premedication before alfaxalone or alfadolone for general
anaesthesia
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_8_
_/_
_0_
_4_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_4_
_1_
_2_
_3_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.3 CONTRAINDICATIONS
Do not use in animals with cardiovascular disease, respiratory disease
or impaired liver or kidney function, animals in
shock, seriously debilitated animals, or